2017-11-13T16:49:44-06:00 2016-12-31 410746749 CLIFTONLARSONALLEN LLP 901 N GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2016-01-01 521006053 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVA 2027838700 701 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 200042654 JENNIFER BREAREY CFO 2027838700 2017-11-13 1 DAVID TRIMNER P00444822 5712279500 67.137.57.251 2017-11-13 14:42:55 ES P 4A34DDD2479D050C8546585CBA089292EB24AB94 982E3A21FD6E1AC52C170B1E2CBCAC2CEA5F6CAD 2016 2018-03-14 21:41:22Z ADVAMED SCOTT WHITAKER 701 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 200042654 35155277 0 X WWW.ADVAMED.ORG X 1974 DE REPRESENT MEDICAL DIAGNOSTICS AND DEVICE MANUFACTURERS ON DOMESTIC & GLOBAL REGULATORY & LEGISLATIVE ISSUES. 51 51 91 55 6009 3367 0 0 32559247 34201714 628621 867895 74366 85668 33262234 35155277 244478 253900 0 0 18008553 19081425 0 0 0 14855453 14866407 33108484 34201732 153750 953545 16276213 15577986 9423929 8329306 6852284 7248680 ADVAMED ADVOCATES ON A GLOBAL BASIS FOR THE HIGHEST ETHICAL STANDARDS, TIMELY PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICAL TECHNOLOGIES, AND ECONOMIC POLICIES THAT REWARD VALUE CREATION. 0 0 ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL AGENCIES. ADVAMED'S ADVOCACY STAFF AND OUTSIDE CONSULTANTS PROVIDE INFORMATION ON POLITICAL AND POLICY DEVELOPMENTS, AND PURSUE THE INDUSTRY'S AGENDA FOR A LEGAL, REGULATORY AND ECONOMIC ENVIRONMENT THAT ADVANCES HEALTH CARE BY ASSURING PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY. TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES, ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDA AND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR PATIENTS TO RECEIVE TIMELY ACCESS TO LIFE CHANGING DEVICES PRODUCED BY ADVAMED MEMBERS. OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS. THESE CONSULTANTS PROVIDE REAL-TIME INFORMATION AND AN INDUSTRY VOICE IN OVERSEAS MARKETS. 0 0 1 1 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 85 0 91 1 1 1 1 JA CH 0 0 0 0 X 51 51 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 X JENNIFER BREAREY 2027838700 701 PENNSYLVANIA AVE NW STE 800 WASHINGTON DC 200042654 ROBERT ABERNATHY DIRECTOR 1.00 X 0 0 0 NACHO ABIA DIRECTOR 1.00 X 0 0 0 PETER ARDUINI DIRECTOR 1.00 X 0 0 0 F MICHAEL BALL DIRECTOR 1.00 X 0 0 0 ANDRE MICHEL BALLESTER DIRECTOR 1.00 X 0 0 0 JOHN BISHOP DIRECTOR 1.00 X 0 0 0 BRIAN BLASER DIRECTOR 1.00 X 0 0 0 SCOTT BROOKS DIRECTOR 1.00 X 0 0 0 ANN BUNNENBERG DIRECTOR 1.00 X 0 0 0 DONALD CASEY DIRECTOR 1.00 X 0 0 0 JAMES CLEMMER DIRECTOR 1.00 X 0 0 0 MICHAEL DALE DIRECTOR 1.00 X 0 0 0 PATRICK DALY DIRECTOR 1.00 X 0 0 0 JOSEPH DEVIVO DIRECTOR 1.00 X 0 0 0 TIMOTHY DUGAN DIRECTOR 1.00 X 0 0 0 DENNIS DURMIS DIRECTOR 1.00 X 0 0 0 DAVID DVORAK DIRECTOR 1.00 X 0 0 0 LISA EARNHARDT DIRECTOR 1.00 X 0 0 0 BRIK EYRE DIRECTOR 1.00 X 0 0 0 CAMILLE FARHAT DIRECTOR 1.00 X 0 0 0 MICHAEL FARRELL DIRECTOR 1.00 X 0 0 0 VINCENT FORLENZA CHAIRMAN 1.00 X X 0 0 0 MICHAEL FRAZZETTE DIRECTOR 1.00 X 0 0 0 TODD FRUCHTERMAN DIRECTOR 1.00 X 0 0 0 MICHAEL GENAU DIRECTOR 1.00 X 0 0 0 JEFF GEORGE DIRECTOR 1.00 X 0 0 0 JOHN GREISCH DIRECTOR 1.00 X 0 0 0 THOMAS HOOK DIRECTOR 1.00 X 0 0 0 BRIAN HUTCHINSON DIRECTOR 1.00 X 0 0 0 JOHN KILCOYNE DIRECTOR 1.00 X 0 0 0 LESTER KNIGHT TREASURER 1.00 X X 0 0 0 KEVIN LOBO DIRECTOR 1.00 X 0 0 0 STEPHEN MACMILLAN DIRECTOR 1.00 X 0 0 0 ALAN MAIN DIRECTOR 1.00 X 0 0 0 V GEORGE MALIEKEL DIRECTOR 1.00 X 0 0 0 JEFFERY MCCAULLEY DIRECTOR 1.00 X 0 0 0 MICHAEL MINOGUE DIRECTOR 1.00 X 0 0 0 MICHAEL MOGUL DIRECTOR 1.00 X 0 0 0 MICHAEL MUSSALLEM DIRECTOR 1.00 X 0 0 0 CAROLL NEUBAUER DIRECTOR 1.00 X 0 0 0 DAVID PEREZ DIRECTOR 1.00 X 0 0 0 MICHAEL PHALEN DIRECTOR 1.00 X 0 0 0 JACK PHILLIPS DIRECTOR 1.00 X 0 0 0 MOJDEH POUL DIRECTOR 1.00 X 0 0 0 GARY PRUDEN DIRECTOR 1.00 X 0 0 0 TIMOTHY RING DIRECTOR 1.00 X 0 0 0 WALTER ROSEBROUGH DIRECTOR 1.00 X 0 0 0 MICHAEL ROUSSEAU DIRECTOR 1.00 X 0 0 0 BRENT SHAFER DIRECTOR 1.00 X 0 0 0 BRADY SHIRLEY DIRECTOR 1.00 X 0 0 0 BENSON SMITH DIRECTOR 1.00 X 0 0 0 DOW WILSON DIRECTOR 1.00 X 0 0 0 JOSEPH WOODY DIRECTOR 1.00 X 0 0 0 NADIM YARED DIRECTOR 1.00 X 0 0 0 GLENN WARNER DIRECTOR 1.00 X 0 0 0 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 40.00 X 809915 0 12537 CHRISTOPHER L WHITE EXEC VP, GENERAL COUNSEL 40.00 X 678550 0 47515 KENNETH MENDEZ CHIEF ADMIN OFFICER 40.00 X 560078 0 49701 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 40.00 X 232972 0 37632 RALPH IVES EXEC VP, GLOBAL STRATEGY 40.00 X 480258 0 32138 DONALD MAY EXEC VP, PMT & HEALTH CARE 40.00 X 477823 0 42268 ANDREW FISH CHIEF STRATEGY OFFICER 40.00 X 748227 0 42544 JUAN CARLOS SCOTT CHIEF ADVOCACY OFFICER 40.00 X 642162 0 49701 JANET TRUNZO EXEC VP, TECH AND REGULATO 40.00 X 539984 0 37856 DAVID NEXON SR. EXEC VP 24.00 X 449034 0 31583 STEVEN BROTMAN SENIOR VP, PAYMENT AND HEA 40.00 X 386120 0 44441 RICHARD PRICE SENIOR VP, PAYMENT AND HEA 40.00 X 338991 0 37101 WANDA MOEBIUS EVP, PUBLIC AFFAIRS 40.00 X 549411 0 36942 6893525 0 501959 48 0 1 0 STORY PARTNERS LLC 1000 POTOMAC STREET NW SUITE 102 WASHINGTON DC 20007 CONSULTING 483434 CROWELL & MORING LLP 1001 PENNSYLVANIA AVENUE NW SUITE WASHINGTON DC 20004 CONSULTING 361828 AVALERE HEALTH LLC 1350 CONNETICUT AVENUE NW SUITE 900 WASHINGTON DC 20036 CONSULTING 360369 SPAG CONSULTING PRIVATE LIMITED 10 ANSON ROAD 26-04 INTERNATIONAL P SINGAPORE IN 079903 CONSULTING 356354 DELOITTE CONSULTING LLP PO BOX 844717 DALLAS TX 75284 CONSULTING 334958 31 MEMBERSHIP DUES 900099 31341524 31341524 SEMINARS 611430 2195002 2195002 SPECIAL PROJECTS 900099 665188 665188 34201714 867895 867895 79659 79659 JOB BOARD REVENUE 900099 6009 6009 6009 35155277 34201714 6009 947554 X 253900 4944020 11675817 906678 858544 696366 518384 35499 3195250 4232201 3167 780421 157013 1605070 1111140 2047882 465251 78223 DUES AND SUBSCRIPTIONS 418882 TRAINING 75023 143001 34201732 323 516 12783260 12788093 972948 547165 454130 239972 5875866 5266372 565331 609494 1454184 1385909 6249 1837 39788 5000 16276213 15577986 4639568 3966978 2495858 2245852 2288503 2116476 9423929 8329306 X 6852284 7248680 6852284 7248680 16276213 15577986 X 953545 -557149 X 0 1 X 1 0 8625 3625 5000 8625 1 MIKE PENCE FOR INDIANA PO BOX 3402 ALEXANDRIA VA 22302 800719483 1000 ADVAMED CALIFORNIA PAC 701 PENNSYLVANIA AVE NW WASHINGTON DC 20004 455309081 5000 COMMITTEE TO RE-ELECT ASSEMBLYMAN JOE MORELLE PO BOX 90714 ROCHESTER NY 14609 161421647 2000 CUSHING FOR SENATE PO BOX 211 HAMPDEN ME 04444 454392142 375 MAINE SENATE REPUBLICAN MAJORITY PO BOX 1 AUGUSTA ME 04332 263733192 250 0 0 1 29406979 3190000 342840 3532840 2793663 739177 PART I-A, LINE 1: ADVAMED PROVIDED $5,000 OF FUNDING TO ADVAMED'S CALIFORNIA PAC AND PROVIDED $1,000, $2,000, $375 AND $250 TO STATE CANDIDATES IN STATES WHERE CORPORATE GIVING IS PERMISSIBLE. 2569114 2460804 108310 834734 729044 105690 2472018 2076524 395494 609494 DEFERRED RENT 488234 DEFERRED COMPENSATION 1385909 DEFERRED TENANT ALLOWANCE 112473 DEFERRED ASSESSMENTS 129860 2116476 X 35335696 180419 180419 35155277 0 35155277 34958398 756666 756666 34201732 0 34201732 PART X, LINE 2: ADVAMED COMPLIES WITH THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT EVALUATED ADVAMED'S TAX POSITIONS AND CONCLUDED THAT IT HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. PART XI, LINE 2D - OTHER ADJUSTMENTS: ADVAMED PAC REVENUE 165,419. ADVAMED CA PAC REVENUE 15,000. PART XII, LINE 2D - OTHER ADJUSTMENTS: ADVAMED PAC EXPENSES 181,617. ADVAMED CA PAC EXPENSES 17,900. ADVAMED PURCHASING GROUP 557,149. EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 2 13 PROGRAM SERVICES CONSULTANT IN ASIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 1385064 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 167485 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 4 PROGRAM SERVICES CONSULTANT IN EUROPE MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 401302 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 144632 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 3 PROGRAM SERVICES MEETINGS TO PROMOTE THE HARMONIZATION OF INTERNATIONAL STANDARDS 342556 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES PREPAYMENTS FOR 2017: STAFF TRAVEL FOR 2015 MEETINGS TO PROMOTE THE HARMONIZATION OF INTL STANDARDS 8582 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES STAFF TRAVEL FOR 2016: MEETINGS TO PROMOTE THE HARMONIZATION OF INTL STANDARDS 40300 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES PREPAYMENTS FOR 2017: MEETINGS TO PROMOTE THE HARMONIZATION OF INTL STANDARDS 30676 NORTH AMERICA - MEXICO AND CANADA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 2287 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 2 PROGRAM SERVICES CONSULTANT IN BRAZIL MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 438113 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 80403 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 0 PROGRAM SERVICES MEETINGS TO PROMOTE THE HARMONIZATION OF INTERNATIONAL STANDARDS 14545 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 2 PROGRAM SERVICES CONSULTANTS IN INDIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 438113 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 18362 2 20 0 4 2 24 2520597 991823 3512420 0 0 0 0 0 0 1 RESEARCH AMERICA 1101 KING STREET STE 520 ALEXANDRIA VA 22314 521609875 501(C)(3) 35000 PROGRAM SUPPORT SOCIETY FOR WOMEN'S HEALTH RESEARCH 1025 CONNECTICUT AVENUE NW SUITE 601 WASHINGTON DC 20036 521694732 501(C)(3) 15000 PROGRAM SUPPORT ALLIANCE FOR AGING RESEARCH 750 17TH STREET NW SUITE 1100 WASHINGTON DC 20006 541379174 501(C)(3) 30000 PROGRAM SUPPORT UNITED SPINAL ASSOCIATION 75-20 ASTORIA BLVD SUITE 120 JACKSON HEIGHTS NY 11370 135612621 501(C)(3) 30000 PROGRAM SUPPORT SPINA BIFIDA-ASSOCIATION OF AMERICA 4590 MACARTHUR BLVD NW SUITE 250 WASHINGTON DC 20007 581342181 501(C)(3) 10000 PROGRAM SUPPORT AIDS INSTITUTE INC 17 DAVIS BLVD SUITE 403 TAMPA FL 33606 650380952 501(C)(3) 10000 PROGRAM SUPPORT FRIENDS OF CANCER RESEARCH 1800 M STREET NW WASHINGTON DC 20036 521983273 501(C)(3) 10000 PROGRAM SUPPORT TAX FOUNDATION 1325 G ST NW WASHINGTON DC 20005 521703065 501(C)(3) 10000 PROGRAM SUPPORT NATIONAL DOWN SYNDROME SOCIETY 666 BROADWAY 8TH FLOOR NEW YORK NY 10012 132992567 501(C)(3) 10000 PROGRAM SUPPORT JDRF 1400 K STREET NW SUITE 725 WASHINGTON DC 20005 510150028 501(C)(3) 20000 PROGRAM SUPPORT NATIONAL HEALTH COUNTIL 1730 M STREET NW SUITE 500 WASHINGTON DC 20036 131624107 501(C)(3) 20000 PROGRAM SUPPORT 11 PART I LINE 2: ADVAMED BUDGETS ANNUALLY FOR CHARITABLE DONATIONS AND OTHER CHARITABLE GIVING THAT IS CLOSELY ALIGNED WITH ITS STRATEGIC PLAN AND MISSION. IN ADDITION, ADVAMED MAY IDENTIFY CAUSES THROUGHOUT THE YEAR THAT MAY REQUIRE REPURPOSING OF FUNDS FROM ANOTHER EXPENSE CATEGORY TO SUPPORT CERTAIN MEDICAL DEVICE ISSUES OR MEMBERSHIP INITIATIVES, ALL SUCH SPENDING IS PROCESSED THROUGH ADVAMED'S PURCHASE ORDER SYSTEM, WHICH REQUIRES SEVERAL LEVELS OF EXECUTIVE APPROVAL BEFORE ANY FUNDING IS MADE. X X 1 1 X X X X X X 1 0 0 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 677807 0 125000 0 7108 0 0 0 12537 0 822452 0 0 0 CHRISTOPHER L WHITE EXEC VP, GENERAL COUNSEL 552297 0 125011 0 1242 0 30895 0 16620 0 726065 0 0 0 KENNETH MENDEZ CHIEF ADMIN OFFICER 449447 0 108309 0 2322 0 30895 0 18806 0 609779 0 0 0 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 204160 0 28398 0 414 0 24581 0 13051 0 270604 0 0 0 RALPH IVES EXEC VP, GLOBAL STRATEGY 395034 0 78366 0 6858 0 30895 0 1243 0 512396 0 0 0 DONALD MAY EXEC VP, PMT & HEALTH CARE 397983 0 79030 0 810 0 30895 0 11373 0 520091 0 0 0 ANDREW FISH CHIEF STRATEGY OFFICER 558275 0 189142 0 810 0 29195 0 13349 0 790771 0 0 0 JUAN CARLOS SCOTT CHIEF ADVOCACY OFFICER 512936 0 128686 0 540 0 30895 0 18806 0 691863 0 0 0 JANET TRUNZO EXEC VP, TECH AND REGULATO 437914 0 95212 0 6858 0 30895 0 6961 0 577840 0 0 0 DAVID NEXON SR. EXEC VP 377475 0 69183 0 2376 0 30895 0 688 0 480617 0 0 0 STEVEN BROTMAN SENIOR VP, PAYMENT AND HEA 326957 0 56841 0 2322 0 30895 0 13546 0 430561 0 0 0 RICHARD PRICE SENIOR VP, PAYMENT AND HEA 283506 0 48627 0 6858 0 30895 0 6206 0 376092 0 0 0 WANDA MOEBIUS EVP, PUBLIC AFFAIRS 474346 0 74525 0 540 0 30895 0 6047 0 586353 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS AUTHORIZED ONLY IN EXCEPTIONAL CIRCUMSTANCES, SUCH AS WHEN IT IS NECESSARY TO TAKE A SPECIFIC FLIGHT WHERE BUSINESS OR COACH CLASS IS NOT AVAILABLE, AND MUST FIRST HAVE PRIOR WRITTEN APPROVAL BY DEPARTMENT HEADS AND ADVAMED'S PRESIDENT. OTHER EXPENSES INCURRED BY THE TRAVELER FOR TRAVEL OUTSIDE THE DEFINITION OF A BUSINESS TRIP, INCLUDING EXPENSES FOR FAMILY MEMBERS TRAVELING WITH THE EMPLOYEE, ARE ALSO THE RESPONSIBILITY OF THE TRAVELER AND NOT ADVAMED. SUCH EXPENSES ARE KEPT SEPARATE FROM REIMBURSABLE BUSINESS EXPENDITURES. PERSONAL TRAVEL FOR FAMILY MEMBERS/FRIENDS MAY BE BOOKED THROUGH ADVAMED'S TRAVEL AGENCY BUT ARE IDENTIFIED SEPARATELY AND BILLED DIRECTLY TO THE EMPLOYEE. THE PRESIDENT OF ADVAMED MAY TRAVEL BUSINESS CLASS ON ALL INTERNATIONAL FLIGHTS AND FOR TRAVEL OVER THREE HOURS IN DURATION WHERE SUCH SEATING IS AVAILABLE. FIRST CLASS SEATING WILL BE REIMBURSED ON DOMESTIC FLIGHTS OVER THREE (3) HOURS IN DURATION IF BUSINESS CLASS SEATING IS NOT OFFERED ON THE FLIGHT. THE ASSOCIATION SHALL REIMBURSE TRAVEL EXPENSES FOR EXECUTIVE'S SPOUSE TO ASSOCIATION EVENTS WHEN ATTENDANCE IS REQUIRED FOR BUSINESS PURPOSES. TRAVEL IS NOT INCLUDED IN TAXABLE INCOME. PART I, LINE 4A WANDA MOEBIUS POST-EMPLOYMENT PAYMENT PAID OF $144,328.80 FORM 990, PART VI, SECTION A, LINE 1 THERE SHALL BE AN EXECUTIVE COMMITTEE, WHICH SHALL CONSIST OF THE PRESIDENT, ELECTED OFFICERS OF THE ASSOCIATION, THE IMMEDIATE PAST CHAIRMAN, THE ADVAMED-DX CHAIRMAN, AND NOT FEWER THAN FIVE NOR MORE THAN TEN MEMBERS OF THE BOARD OF DIRECTORS AT LARGE, WHO SHALL BE ELECTED TO THAT POSITION, FOR A PERIOD OF ONE YEAR AND THEREAFTER UNTIL A SUCCESSOR SHALL HAVE BEEN DULY ELECTED AND QUALIFIED, BY A MAJORITY OF THE ENTIRE BOARD OF DIRECTORS ANNUALLY. THE EXECUTIVE COMMITTEE SHALL PERFORM SUCH DUTIES AS MAY BE DELEGATED TO IT BY THE BOARD OF DIRECTORS, AND MAY FURTHER ACT FOR AND ON BEHALF OF THE BOARD OF DIRECTORS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS, PROVIDED THAT ALL SUCH ACTS SHALL BE FULLY REPORTED TO THE BOARD OF DIRECTORS AT OR BEFORE ITS NEXT MEETING FOR ITS REVIEW AND APPROPRIATE ACTION, IF REQUIRED OR DEEMED NECESSARY. FORM 990, PART VI, SECTION A, LINE 6 ANY FIRM OR CORPORATION WHICH, THROUGH ITSELF OR THROUGH ANY OF ITS SUBSIDIARIES OR DIVISIONS, IS SIGNIFICANTLY ENGAGED IN THE MANUFACTURE OF AND/OR THE RESEARCH WITH THE INTENT TO MANUFACTURE MEDICAL DEVICES, DIAGNOSTIC PRODUCTS AND/OR HEALTH CARE INFORMATION SYSTEMS WITHIN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, SHALL BE ELIGIBLE FOR ACTIVE MEMBERSHIP. FORM 990, PART VI, SECTION A, LINE 7A EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP, INCLUDING THE ELECTION OF ONE THIRD OF THE BOARD OF DIRECTORS ANNUALLY. THE BOARD NOMINATING AND GOVERNANCE COMMITTEE PRESENTS A PROPOSED SLATE OF DIRECTORS ANNUALLY TO THE MEMBERSHIP FOR VOTE. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. FORM 990, PART VI, SECTION A, LINE 7B EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. SUCH OFFICIAL REPRESENTATIVE SHALL BE THE CHIEF EXECUTIVE OFFICER OR CHIEF OPERATING OFFICER OF THE MEMBER OR SUCH OTHER SENIOR OPERATING OFFICER AS THE CHIEF EXECUTIVE OFFICER MAY DESIGNATE. FORM 990, PART VI, SECTION B, LINE 11B ADVAMED'S CHIEF FINANCIAL OFFICER AND CONTROLLER PERFORM AN INDEPTH REVIEW OF THE DRAFT 990. THE GENERAL COUNSEL REVIEWS THE FINAL DRAFT PRIOR TO SUBMITTING TO THE FINANCE AND AUDIT COMMITTEE (FAC). UPON THE FAC'S REVIEW THE 990 IS SUBMITTED TO THE FULL BOARD FOR THEIR REVIEW. PROVIDED NO CONCERNS ARE RAISED PRIOR TO THE END OF THE REVIEW PERIOD, THE 990 IS THEN FINALIZED AND SUBMITTED TO THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ADVAMED HAS IN PLACE A CONFLICT OF INTEREST POLICY THAT IS MONITORED REGULARLY. EXCERPTS FROM THE POLICY RELATED TO THIS QUESTION ARE SHOWN BELOW: THE CONFLICT OF INTEREST POLICY OF ADVAMED: (1) DEFINES CONFLICTS OF INTEREST; (2) IDENTIFIES CLASSES OF INDIVIDUALS WITHIN THE ASSOCIATION COVERED BY THIS POLICY; (3) FACILITATES DISCLOSURE OF INFORMATION THAT MAY HELP IDENTIFY CONFLICTS OF INTEREST; AND (4) SPECIFIES PROCEDURES TO BE FOLLOWED IN MANAGING CONFLICTS OF INTEREST. 1. A CONFLICT OF INTEREST ARISES WHEN A PERSON IN A POSITION OF AUTHORITY OVER THE ASSOCIATION MAY BENEFIT FINANCIALLY FROM A DECISION HE OR SHE COULD MAKE IN THAT CAPACITY, INCLUDING INDIRECT BENEFITS SUCH AS TO FAMILY MEMBERS OR BUSINESSES WITH WHICH THE PERSON IS CLOSELY ASSOCIATED. ADVAMED'S POLICY IS FOCUSED UPON MATERIAL FINANCIAL INTEREST OF, OR BENEFIT TO, SUCH PERSONS. 2. PERSONS COVERED BY THIS POLICY ARE THE ASSOCIATION'S STAFF, OFFICERS, DIRECTORS, CHIEF EXECUTIVE OFFICER, AND CHIEF ADMINISTRATIVE OFFICER. 3. PERSONS COVERED BY THIS POLICY ANNUALLY DISCLOSE TO THE GENERAL COUNSEL ON A FORM PROVIDED BY THE ASSOCIATION THEIR INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, SUBSTANTIAL BUSINESS OR INVESTMENT HOLDINGS, AND OTHER TRANSACTIONS OR AFFILIATIONS WITH BUSINESSES AND OTHER ORGANIZATIONS OR THOSE OF FAMILY MEMBERS. 4. FOR EACH INTEREST DISCLOSED TO THE GENERAL COUNSEL, THE GENERAL COUNSEL WILL DETERMINE WHETHER TO: (A) TAKE NO ACTION; (B) ASSURE FULL DISCLOSURE TO THE BOARD OF DIRECTORS AND OTHER INDIVIDUALS COVERED BY THIS POLICY; (C) ASK THE PERSON TO RECUSE FROM PARTICIPATION IN RELATED DISCUSSIONS OR DECISIONS WITHIN THE ASSOCIATION; OR (D) ASK THE PERSON TO RESIGN FROM HIS OR HER POSITION IN THE ASSOCIATION OR, IF THE PERSON REFUSES TO RESIGN, BECOME SUBJECT TO POSSIBLE REMOVAL IN ACCORDANCE WITH THE ASSOCIATION'S REMOVAL PROCEDURES. THE ASSOCIATION'S CHIEF ADMINISTRATIVE OFFICER AND VICE PRESIDENT OF FINANCE WILL MONITOR PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND DISCLOSE THEM TO THE CHAIRMAN OF THE BOARD OF DIRECTORS IN ORDER TO DEAL WITH POTENTIAL OR ACTUAL CONFLICTS, WHETHER DISCOVERED BEFORE OR AFTER THE TRANSACTION HAS OCCURRED. INTERESTS IN MEMBER COMPANIES: AT TIMES, ADVAMED STAFF AND/OR DIRECTORS MAY BE AWARE OF THE SIGNIFICANT AMOUNT OF INTEREST GENERATED IN CONNECTION WITH NEW PRODUCT DEVELOPMENT, SALES AND PROFITS, PRODUCT REGULATORY STATUS, AND ACQUISITIONS IN THE HEALTH CARE TECHNOLOGY INDUSTRY, THUS, ANYONE IN POSSESSION OF MATERIAL INFORMATION NOT GENERALLY AVAILABLE TO THE INVESTING PUBLIC MUST, IN ORDER TO COMPLY WITH THIS POLICY, EITHER DISCLOSE THAT KNOWLEDGE OR REFRAIN FROM TRADING IN THE STOCK. IN ADDITION, THE PURCHASE OF STOCK IN MEMBER COMPANIES CAN LEAD TO THE APPEARANCE THAT A MEMBER OF THE STAFF AND/OR BOARD OF DIRECTORS IS FAVORING THE INTERESTS OF THAT COMPANY BECAUSE OF SUCH FINANCIAL INTEREST. EVEN IF THERE IS NO ACTUAL CONFLICT OF INTEREST, THE APPEARANCE OF IMPROPRIETY MUST BE AVOIDED. NO EMPLOYEE OF THE ASSOCIATION OR MEMBER OF ITS BOARD OF DIRECTORS, EITHER IN HIS OR HER OWN NAME, OR IN THE NAME OF HIS OR HER SPOUSE OR CHILDREN, MAY PURCHASE STOCK IN ANY MEMBER COMPANY WITHOUT ADVISING THE ASSOCIATION PRESIDENT OF SUCH OWNERSHIP OR CONTEMPLATED OWNERSHIP. IN 2010, ADVAMED REQUIRED EMPLOYEES AND DIRECTORS TO SUBMIT AN ANNUAL FINANCIAL DISCLOSURE STATEMENT TO THE GENERAL COUNSEL REGARDING HOLDINGS IN MEMBER COMPANIES. AFTER REVIEW OF THE COMPLETED FORMS BY THE GENERAL COUNSEL, POTENTIAL CONFLICTS ARE REPORTED TO THE PRESIDENT, WHO REPORTS ANY SUCH DISCLOSURES TO THE CHAIRMAN OF THE BOARD OF DIRECTORS. INTEREST IN ENTITIES DOING BUSINESS WITH ADVAMED: IN THE COURSE OF ITS DAY-TO-DAY OPERATIONS, ADVAMED CONTRACTS WITH NUMEROUS FIRMS THAT PROVIDE GOODS AND SERVICES. IT IS IMPORTANT THAT THESE FIRMS ARE CHOSEN FOR BUSINESS PURPOSES AND NOT BECAUSE THEY ARE INAPPROPRIATELY FAVORED BY ADVAMED EMPLOYEES OR DIRECTORS WHO MAY HAVE A FINANCIAL INTEREST IN PARTICULAR TRANSACTIONS. ACCORDINGLY, ADVAMED EMPLOYEES AND DIRECTORS MUST DISCLOSE, ON AN ONGOING BASIS, ANY FINANCIAL INTEREST IN A COMPANY WITH WHICH ADVAMED CONTRACTS, OR IS CONSIDERING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS INCLUDES ALL OF THESE ELEMENTS: (1) REVIEW AND APPROVAL BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION; (2) USE OF DATA AS TO COMPARABLE COMPENSATION; AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. 1. REVIEW AND APPROVAL: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. 2. USE OF DATA AS TO COMPARABLE COMPENSATION: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. 3. CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING: THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). FORM 990, PART IX, LINE 11G OTHER CONSULTING EXPENSE 4,232,201. FORM 990, PART XI, LINE 9: CHANGE IN EQUITY IN ADVAMED PURCHASING GROUP -557,149. ADVANCED MEDICAL TECHNOLOGY ASSOCIATION POLITICAL ACTION COMMITTEE 701 PENNSYLVANIA AVENUE NW STE 800 WASHINGTON DC 20004 522134566 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION CA PAC 701 PENNSYLVANIA AVENUE NW STE 800 WASHINGTON DC 20004 455309081 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 MEDTECH CONFERENCE PARTNERS LLC 701 PENNSYLVANIA AVENUE NW STE 800 WASHINGTON DC 20004 364725626 TRADE SHOW DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION RELATED 821654 647338 1 1 0.50000 ADVAMED PURCHASING GROUP INC 701 PENNSYLVANIA AVE NW STE 800 WASHINGTON DC 20004 812764022 GROUP PURCHASING PROGRAM DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION C 1.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1 MEDTECH CONFERENCE PARTNERS LLC S 1198253 CASH